Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,281 signal articles · 44 in last 24h · 115,462 total before filter · latest 1h ago
44last 24h
1764last 7d
297● bullish (7d)
170● bearish (7d)
205publishers
AllMacro315Earnings817M&A103Regulatory25Product16Analyst26
✕ clear all filterssentiment: bearishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Under Armour stock drops: AlphaSpace chart breakdown
Yahoo Finance Video8d agobearishVIDEO
Under Armour stock drops: AlphaSpace chart breakdown

Yahoo Finance Senior Reporter Brooke DiPalma and Yahoo Finance Markets and Data Editor Jared Blikre take a closer look at Under Armour (UAA) stock, which drops on the company's disappointing outlook. Yahoo Finance's AlphaSpace is a premium investment platform that combines data, charting, news, analysis, and more to help retail investors understand markets.

Johnson & Johnson (JNJ) Reaches $5.5 Billion Talc Settlement To Close Years Of Lawsuits
Simply Wall St.8d agobearish
Johnson & Johnson (JNJ) Reaches $5.5 Billion Talc Settlement To Close Years Of Lawsuits

Johnson & Johnson (NYSE: JNJ) agreed to a US$5.5b settlement to resolve tens of thousands of talc baby powder lawsuits. The deal ends decades of litigation over alleged health risks tied to the company’s talc-based products. The settlement follows years of high profile trials and failed bankruptcy attempts related to the talc claims. This resolution removes a long running legal overhang and brings more clarity for Johnson & Johnson investors. Consider broadening your research to other large...

What Do Boston Scientific (BSX) Recalls Mean For Device Safety And Clinical Use?
Simply Wall St.8d agobearish
What Do Boston Scientific (BSX) Recalls Mean For Device Safety And Clinical Use?

Boston Scientific (NYSE: BSX) has initiated multiple product recalls covering cardiac ablation generators and vascular access sheaths due to labeling discrepancies and air embolism risks. The recalls affect a broad mix of devices used in cardiac and vascular procedures across several international markets. Regulators and hospitals are assessing the implications for device safety protocols, clinical workflows, and future use of the impacted products. Product safety questions can prompt...

China opens formal probe into Palo Alto just as stock hits highs
TheStreet8d agobearish
China opens formal probe into Palo Alto just as stock hits highs

In March 2023, China opened its first-ever cybersecurity review into a foreign company’s products. The target was Micron, the Idaho-based memory chipmaker, CNBC reported, and the case ended seven weeks later with a ban on the sale of its products to Chinese state infrastructure operators. That ...

The Bull Case For Trade Desk (TTD) Could Change Following Q3 Guidance Cut And Execution Missteps – Learn Why
Simply Wall St.8d agobearish
The Bull Case For Trade Desk (TTD) Could Change Following Q3 Guidance Cut And Execution Missteps – Learn Why

The Trade Desk, Inc. has already reported its second-quarter 2026 results, with sales rising to US$715.06 million while net income and earnings per share declined year on year, alongside a completed share repurchase program totaling 48,644,000 shares for US$2.49 billions since 2023. The earnings miss versus analyst expectations and weaker third-quarter revenue guidance, attributed by management to macro pressures and execution issues, have prompted several broker downgrades and raised fresh...

Fiserv (FISV) Could Be 55% Below Fair Value After Earnings Miss And Guidance Cut
Simply Wall St.8d agobearish
Fiserv (FISV) Could Be 55% Below Fair Value After Earnings Miss And Guidance Cut

Fiserv (FISV) is back in focus after its second quarter 2026 earnings report, where revenue and earnings came in below market expectations and the company cut its full year guidance for revenue and adjusted earnings. See our latest analysis for Fiserv. Fiserv’s share price has been under pressure, with the year to date share price return down 17.5% and the 1 year total shareholder return down 59.2%, as the earnings miss, guidance cut and recent activist pressure have shifted sentiment despite...

SK Hynix Slides and the ProShares Ultra SK Hynix ETF (SKHU) Tumbles With It
24/7 Wall St.8d agobearish
SK Hynix Slides and the ProShares Ultra SK Hynix ETF (SKHU) Tumbles With It

The ProShares Ultra SK Hynix ETF (NYSEARCA:SKHU) is sliding hard in Friday’s session, extending a punishing stretch for the newly launched, geared-daily product. The catalyst: SK Hynix’s US-listed ADR has come under fresh pressure this week after the company’s preliminary second-quarter revenue, while up sharply year over year, arrived below Street expectations that had run ... SK Hynix Slides and the ProShares Ultra SK Hynix ETF (SKHU) Tumbles With It

DUST Drops 13% as Gold Miners Rally Hard
24/7 Wall St.8d agobearish
DUST Drops 13% as Gold Miners Rally Hard

Gold miners are tearing higher on blowout earnings and record-near gold prices, leaving one popular inverse fund in freefall and raising serious questions about what compounding decay does to traders caught on the wrong side of a trend.

Is Resilient Q2 Sales During Restructuring Altering The Investment Case For Autodesk (ADSK)?
Simply Wall St.8d agobearish
Is Resilient Q2 Sales During Restructuring Altering The Investment Case For Autodesk (ADSK)?

In the past week, Autodesk reported steady fiscal Q2 sales trends despite its ongoing restructuring, with partners successfully adjusting to the company’s newer transaction model, according to recent commentary. Investors are also watching closely ahead of the previously scheduled 27 August 2026 earnings release, where analysts had been expecting year-on-year growth in both earnings and revenue. What stands out is that Autodesk’s operational reshaping appears to be progressing without major...